📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Oxford Pharmascience

1.1 - Company Overview

Oxford Pharmascience Logo

Oxford Pharmascience

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of proprietary technology platforms to re-develop existing medicines to make them better, safer or easier to take, licensing its technologies and dossiers to a network of partners rather than manufacturing or selling directly to consumers.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Oxford Pharmascience

CohBar Logo

CohBar

HQ: United States Website
  • Description: Provider of mitochondria-based therapeutics as a clinical-stage biotechnology company developing CB4211 for NASH and obesity, showing reduced liver damage biomarkers and glucose levels; CB5138 analogs in preclinical development for IPF and other fibrotic diseases, reducing lung fibrosis and inflammation; and a Mitochondrial Genome Mining platform to discover therapeutic peptides.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CohBar company profile →
Facet Biotech Logo

Facet Biotech

HQ: United States Website
  • Description: Provider of biotechnology research and development focused on identifying and developing oncology drugs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Facet Biotech company profile →
Innovation Pharmaceuticals Logo

Innovation Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies addressing unmet medical needs, developing Brilacidin, a small-molecule drug candidate with immunomodulatory, anti-inflammatory, and antimicrobial properties tested for COVID-19, oral mucositis, inflammatory bowel disease, serious skin infections, and fungal diseases; and BEAMED, an image-guided surgical laser platform under development for treating cancer and epilepsy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Innovation Pharmaceuticals company profile →
Oxford Biomedica Logo

Oxford Biomedica

HQ: United Kingdom Website
  • Description: Provider of gene and cell therapy solutions, offering lentiviral LentiVector and AAV platforms for development and manufacturing of gene therapies, plus CDMO services for viral vectors including tech transferred-in execution of client-defined methods, process development, GMP manufacturing, and regulatory support.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oxford Biomedica company profile →
Dyax Logo

Dyax

HQ: United States Website
  • Description: Provider of biotherapeutics focused on the discovery, development and commercialization for unmet medical needs, with an emphasis on inflammatory and oncology indications; lead product DX-88 approved under the brand name KALBITOR (ecallantide) by the United States Food and Drug.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Dyax company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Oxford Pharmascience

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Oxford Pharmascience

2.2 - Growth funds investing in similar companies to Oxford Pharmascience

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Oxford Pharmascience

4.2 - Public trading comparable groups for Oxford Pharmascience

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Oxford Pharmascience

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Oxford Pharmascience

What does Oxford Pharmascience do?

Oxford Pharmascience is a provider of proprietary technology platforms to re-develop existing medicines to make them better, safer or easier to take, licensing its technologies and dossiers to a network of partners rather than manufacturing or selling directly to consumers.

Who are Oxford Pharmascience's competitors?

Oxford Pharmascience's competitors and similar companies include CohBar, Facet Biotech, Innovation Pharmaceuticals, Oxford Biomedica, and Dyax.

Where is Oxford Pharmascience headquartered?

Oxford Pharmascience is headquartered in United Kingdom.

How many employees does Oxford Pharmascience have?

Oxford Pharmascience has 1,000 employees 🔒.

When was Oxford Pharmascience founded?

Oxford Pharmascience was founded in 2010 🔒.

What sector and industry vertical is Oxford Pharmascience in?

Oxford Pharmascience is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Oxford Pharmascience

Who are the top strategic acquirers in Oxford Pharmascience's sector and industry

Top strategic M&A buyers and acquirers in Oxford Pharmascience's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Oxford Pharmascience?

Top strategic M&A buyers groups and sectors for Oxford Pharmascience include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Oxford Pharmascience's sector and industry vertical

Which are the top PE firms investing in Oxford Pharmascience's sector and industry vertical?

Top PE firms investing in Oxford Pharmascience's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Oxford Pharmascience's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Oxford Pharmascience's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Oxford Pharmascience's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Oxford Pharmascience include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Oxford Pharmascience's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Oxford Pharmascience?

The key public trading comparables and valuation benchmarks for Oxford Pharmascience include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Oxford Pharmascience for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Oxford Pharmascience with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Oxford Pharmascience's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Oxford Pharmascience with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Oxford Pharmascience's' sector and industry vertical?

Access recent funding rounds and capital raises in Oxford Pharmascience's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Oxford Pharmascience

Launch login modal Launch register modal